跳至主要内容
临床试验/NCT00948558
NCT00948558Unknown不适用

Citrate Pharmacokinetics in Healthy Individuals and Critically Ill Patients and the Application of Regional Citrate Anticoagulation in Continuous Renal Replacement Therapy(RCA-CRRT).

Huashan Hospital1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2009年3月最近更新:
适应症

试验速览

阶段
不适用
入组人数
40
试验地点
1

研究概览

简要总结

  1. To compare the differences of citrate pharmacokinetics in healthy individuals and critically ill patients as well as the influential factors.
  2. To validate a pharmacokinetic model which has been established in a formal paper.
  3. To create a safe and effective RCA-CRRT protocol.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • healthy individuals, none-pregnant
  • diagnosed with acute renal failure according to RIFLE criteria
  • ARF with hepatic insufficiency
  • ARF with MODS or sepsis
  • within informed consent

排除标准

  • used drugs with citrate within one week
  • infused with blood,plasma or platelet or undergone plasma exchange therapy within 48 hours
  • serious alkalosis with PH>7.55
  • serious lactic acidosis
  • not in resuscitation state

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验

尚未招募
不适用
A prospective study conducted in an adult intensive care unit to measure the breakdown products of citrate during kidney dialysis
ACTRN12619000590167Sunshine Coast University Hospital20
已完成
2 期
Citrate pharmacokinetics in acute liver failure clinically ill patients receiving continuous renal replacement therapyLiver failureCitrate ToxicityRegional Citrate AnticoagulationLiver Failure, AcuteLiver Failure, Acute on ChronicPharmacokineticContinuous Renal Replacement TherapyRegional citrate anticoagulationPharmacokineticsCRRTCirrhosis
TCTR20210707010Excellence Center for Critical Care Nephrology, King Chulalongkorn Memorial Hospital14
已完成
不适用
Citrate Pharmacokinetics in Critically Ill Liver Failure Patients Receiving CRRTCitrate ToxicityRegional Citrate AnticoagulationLiver Failure, AcuteLiver Failure, Acute on ChronicPharmacokineticContinuous Renal Replacement Therapy
NCT04959110Chulalongkorn University20
已完成
2 期
Biological Effects of Citrate-buffered Solutions on Dialysis Efficiency and Systemic InflammationRenal Insufficiency, ChronicInflammation
NCT03577249A.O.U. Città della Salute e della Scienza45
进行中(未招募)
不适用
Phase I and II perspective study with Citrate in Liposoma not Pegilate Doxorubicine TLC D-99 in association to Ifosfamide in patients with metastatic soft tissue sarcoma.TREATMENT OF PATIENTS AFFECTED WITH SOFT TISSUE SARCOMA IN METASTATIC PHASEMedDRA version: 9.1Level: PTClassification code 10039491Term: Sarcoma
EUCTR2005-004569-40-ITISTITUTO CLINICO HUMANITAS52